Cost Effectiveness of Hematopoietic Stem Cell Transplantation Compared with Transfusion Chelation for Treatment of Thalassemia Major

Verma, 2011, Past, present & future scenario of thalassaemic care & control in India, Indian J Med Res, 134, 507 Madan, 2010, Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India, Indian J Hum Genet, 16, 16, 10.4103/0971-6866.64941 Mohanty, 2013, Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study, J Community Genet, 4, 33, 10.1007/s12687-012-0114-0 Trehan, 2015, Clinicoinvestigational and demographic profile of children with thalassemia major, Indian J Hematol Blood Transfus, 31, 121, 10.1007/s12288-014-0388-y Angelucci, 2014, 1 Borgna-Pignatti, 2004, Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine, Haematologica, 89, 1187 Moirangthem, 2017, Socio-demographic profile and economic burden of treatment of transfusion dependent thalassemia, Indian J Pediatr, 82, 102, 10.1007/s12098-017-2478-y Caocci, 2012, Health related quality of life in Middle Eastern children with beta-thalassemia, BMC Blood Disord, 12, 6, 10.1186/1471-2326-12-6 Atkin, 2001, Living a “normal” life: young people coping with thalassaemia major or sickle cell disorder, Soc Sci Med, 53, 615, 10.1016/S0277-9536(00)00364-6 Donnall Thomas, 1982, Marrow transplantation for thalassaemia, Lancet, 320, 227, 10.1016/S0140-6736(82)90319-1 Caocci, 2017, Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment, Am J Hematol, 92, 1303, 10.1002/ajh.24898 Younger, 2016, Health care in India, Neurol Clin, 34, 1103, 10.1016/j.ncl.2016.06.005 Ministry of Statistics and Programme Implementation NSSO 71st R, Health in India, Government of India Prinja, 2012, Health care inequities in north India: role of public sector in universalizing health care, Indian J Med Res, 136, 421 Prinja, 2013, Equity in hospital services utilisation in india, Econ Polit Wkly, xlviiI, 52 National Health Mission (NHM), Ministry of Health & Family Welfare Government of India, Rashtriya Bal Swasthya Karyakram (RBSK) Khera, 2012, Economics of hematopoietic cell transplantation, Blood, 120, 1545, 10.1182/blood-2012-05-426783 Sruamsiri, 2013, Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared with hypertransfusion and iron chelation program, BMC Health Serv Res, 13, 1, 10.1186/1472-6963-13-45 Osborne, 2007, Quality of life related to oral versus subcutaneous iron chelation: a time trade-off study, Value Heal, 10, 451, 10.1111/j.1524-4733.2007.00200.x Karnon, 2008, Cost-utility analysis of deferasirox compared with standard therapy with desferrioxamine for patients requiring iron chelation therapy in the United Kingdom, Curr Med Res Opin, 24, 1609, 10.1185/03007990802077442 Slovacek, 2005, Global quality of life in patients who have undergone the hematopoietic stem cell transplantation: finding from transversal and retrospective study, Exp Oncol, 27, 238 Prinja, 2017, Health technology assessment for policy making in india: current scenario and way forward, Pharmacoecon Open, 2, 1, 10.1007/s41669-017-0037-0 Forex News Registrar General & Census Commissioner of India Prinja, 2017 Husereau, 2013, Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR health economic evaluations publication guidelines task force, Value Heal, 16, 231, 10.1016/j.jval.2013.02.002 Trading Economics Prinja, 2015, A systematic review of the state of economic evaluation for health care in India, Appl Health Econ Health Policy, 13, 595, 10.1007/s40258-015-0201-6 National Institute for Health and Care Excellence (NICE) WHO Commission on Macroeconomics and Health, 2001 Woods, 2016, Country-level cost-effectiveness thresholds: initial estimates and the need for further research, Value Heal, 19, 929, 10.1016/j.jval.2016.02.017 Prinja, 2017, Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program, Cancer, 123, 3253, 10.1002/cncr.30734 Leelahavarong, 2010, A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand, BMC Health Serv Res, 10, 209, 10.1186/1472-6963-10-209 Sharma, 2014, Cost of hematopoietic stem cell transplantation in India, Mediterr J Hematol Infect Dis, 6, e2014046, 10.4084/mjhid.2014.046 Gupta, 2017, Pediatric hematopoietic stem cell transplantation in india: status, challenges and the way forward: based on Dr. K. C. chaudhuri oration 2016, Indian J Pediatr, 84, 36, 10.1007/s12098-016-2253-5 Groopman, 2017, The power of regret, N Engl J Med, 377, 1507, 10.1056/NEJMp1709917 Angelucci, 2014, Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: Indications and management recommendations from an international expert panel, Haematologica, 99, 811, 10.3324/haematol.2013.099747 Lee, 1997, Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: A decision analysis, Ann Intern Med, 25 Chern, 2007, Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan, Pediatr Blood Cancer, 48, 550, 10.1002/pbc.21028 Tubman, 2016, Thalassemia: Report of the thalassemia longitudinal cohort, J Pediatr Hematol Oncol, 37, 1 Tubman, 2015, Guidelines for the standard monitoring of patients with thalassemia: Report of the thalassemia longitudinal cohort, J Pediatr Hematol Oncol, 37, e162, 10.1097/MPH.0000000000000307 Jain, 2012, A prospective study for prevalence and/or development of transfusion-transmitted infections in multiply transfused thalassemia major patients, Asian J Transfus Sci, 6, 151, 10.4103/0973-6247.98919